ADAM33

ADAM33
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesADAM33, C20orf153, DJ964F7.1, ADAM metallopeptidase domain 33
External IDsOMIM: 607114; MGI: 1341813; HomoloGene: 11881; GeneCards: ADAM33; OMA:ADAM33 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001282447
NM_025220
NM_153202

NM_001163529
NM_033615

RefSeq (protein)

NP_001269376
NP_079496
NP_694882

NP_001157001
NP_291093

Location (UCSC)Chr 20: 3.67 – 3.68 MbChr 2: 130.89 – 130.91 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Disintegrin and metalloproteinase domain-containing protein 33 is an enzyme that in humans is encoded by the ADAM33 gene.[5][6]

Function

[edit]

This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. This protein is a type I transmembrane protein implicated in asthma and bronchial hyperresponsiveness.[7] Alternative splicing of this gene results in two transcript variants encoding different isoforms.[6]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000149451Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000027318Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Yoshinaka T, Nishii K, Yamada K, Sawada H, Nishiwaki E, Smith K, et al. (January 2002). "Identification and characterization of novel mouse and human ADAM33s with potential metalloprotease activity". Gene. 282 (1–2): 227–236. doi:10.1016/S0378-1119(01)00818-6. PMID 11814695.
  6. ^ a b "Entrez Gene: ADAM33 ADAM metallopeptidase domain 33".
  7. ^ Davies ER, Kelly JF, Howarth PH, Wilson DI, Holgate ST, Davies DE, et al. (2016-07-21). "Soluble ADAM33 initiates airway remodeling to promote susceptibility for allergic asthma in early life". JCI Insight. 1 (11). doi:10.1172/jci.insight.87632. ISSN 0021-9738. PMC 4968941. PMID 27489884.

Further reading

[edit]
[edit]